Percipio Biotherapeutics, Inc.
|Percipio Biotherapeutics, Inc. Patent applications|
|Patent application number||Title||Published|
|20100136013||CD55-INTERACTION PARTNERS AND THE USES THEREOF - The invention relates to the use of a binding member that binds to both SCR1 and SCR2 of CD55 in the treatment of tumours and leukaemia. The binding member may be an antibody that binds to SCR1 and SCR2 of CD55 and neutralizing CD55 and making cancer cells susceptible to complement-mediated attack.||06-03-2010|